Scidev Ltd
ASX:SDV
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.22
0.64
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Scidev Ltd
Scidev Ltd
Cost of Revenue
Scidev Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Scidev Ltd
ASX:SDV
|
Cost of Revenue
-AU$75.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-106%
|
CAGR 10-Years
-108%
|
|
|
Secos Group Ltd
ASX:SES
|
Cost of Revenue
-AU$11.3m
|
CAGR 3-Years
23%
|
CAGR 5-Years
10%
|
CAGR 10-Years
6%
|
|
|
Orica Ltd
ASX:ORI
|
Cost of Revenue
-AU$5.9B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-4%
|
|
|
Calix Ltd
ASX:CXL
|
Cost of Revenue
-AU$13.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
|
C
|
Carbonxt Group Ltd
ASX:CG1
|
Cost of Revenue
-AU$9.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Range International Ltd
ASX:RAN
|
Cost of Revenue
-$714.7k
|
CAGR 3-Years
39%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Scidev Ltd
Glance View
SciDev Ltd. engages in the manufacture and supply of chemicals for industrial wastewater treatment. The company is headquartered in Kings Park, New South Wales. The company went IPO on 2002-05-02. The firm is focused on delivering process control, professional services and chemistry in the mining, construction, water treatment and oil and gas markets. The Company’s products include MaxiFlox and MaxiDry. MaxiFlox and MaxiDry chemistries are designed for a range of applications, including wastewater treatment in construction, mining, mineral processing, oil & gas and water sectors. MaxiFlox and MaxiDry products are supplied in and liquid form, as well as a range of molecular weights, charge distributions and charge densities. The Company’s products also include MaxiFlox organic liquid coagulants, MaxiFlox inorganic liquid coagulant blends, MaxiFlox cationic & anionic flocculant emulsions, MaxiFlox cationic & anionic flocculant powders, MaxiFlox mud solidification polymers, MaxiFlox antifoam products and MaxiDry filter aids.
See Also
What is Scidev Ltd's Cost of Revenue?
Cost of Revenue
-75.1m
AUD
Based on the financial report for Jun 30, 2024, Scidev Ltd's Cost of Revenue amounts to -75.1m AUD.
What is Scidev Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-108%
Over the last year, the Cost of Revenue growth was -15%. The average annual Cost of Revenue growth rates for Scidev Ltd have been -32% over the past three years , -106% over the past five years , and -108% over the past ten years .
You don't have any saved screeners yet
